Short-Term Administration of Lemon Balm Extract Ameliorates Myocardial Ischemia/Reperfusion Injury: Focus on Oxidative Stress
Overview
Authors
Affiliations
We aimed to investigate the cardioprotective effects of ethanolic L. extract (ME) in the rat model of myocardial ischemia/reperfusion (I/R) injury. Thirty-two rats were randomly divided into a CTRL non-treated control group with myocardial I/R injury and three experimental groups of rats treated with 50, 100, or 200 mg/kg of ME for 7 days per os. Afterward, hearts were isolated, and cardiodynamic function was assessed via the Langendorff model of global 20 min ischemia and 30 min reperfusion. Oxidative stress parameters were determined spectrophotometrically from the samples of coronary venous effluent (O, HO, TBARS, and NO,) and heart tissue homogenate (TBARS, NO, SOD, and CAT). H/E and Picrosirius red staining were used to examine cardiac architecture and cardiac collagen content. ME improved cardiodynamic parameters and achieved to preserve cardiac architecture after I/R injury and to decrease fibrosis, especially in the ME200 group compared to CTRL. ME200 and ME100 markedly decreased prooxidants TBARS, O, and HO while increasing NO. Hereby, we confirmed the ME`s ability to save the heart from I/R induced damage, even after short-term preconditioning in terms of preserving cardiodynamic alterations, cardiac architecture, fibrosis, and suppressing oxidative stress, especially in dose of 200 mg/kg.
Dai J, Qiu L, Lu Y, Li M Front Endocrinol (Lausanne). 2024; 15:1366285.
PMID: 39403576 PMC: 11471557. DOI: 10.3389/fendo.2024.1366285.
Bassetto R, Amadio E, Ciampanelli F, Perin S, Ilari P, Gaballo P Front Nutr. 2024; 11:1394330.
PMID: 38769992 PMC: 11102985. DOI: 10.3389/fnut.2024.1394330.
Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome.
Ravic M, Srejovic I, Novakovic J, Andjic M, Sretenovic J, Muric M Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675485 PMC: 11053642. DOI: 10.3390/ph17040525.
Camphene as a Protective Agent in Myocardial Ischemia/Reperfusion Injury.
Stamatiou R, Anagnostopoulou M, Ioannidou-Kabouri K, Rapti C, Lazou A Antioxidants (Basel). 2024; 13(4).
PMID: 38671853 PMC: 11047447. DOI: 10.3390/antiox13040405.
Kawara R, Moawed F, Elsenosi Y, Elmaksoud H, Ahmed E, Abo-Zaid O BMC Complement Med Ther. 2024; 24(1):71.
PMID: 38303002 PMC: 10832092. DOI: 10.1186/s12906-024-04370-z.